{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06358950",
            "orgStudyIdInfo": {
                "id": "ALKS 2860-201"
            },
            "organization": {
                "fullName": "Alkermes, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)",
            "officialTitle": "A Phase 2, Parallel-Group, Dose-Range-Finding Study With Randomized Double-Blind Treatment and Open-Label Periods to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Narcolepsy Type 1",
            "acronym": "Vibrance-1",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-evaluate-the-safety-and-effectiveness-of-alks-in-subjects-with-narcolepsy-type-alks"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-03-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-04-02",
            "studyFirstSubmitQcDate": "2024-04-05",
            "studyFirstPostDateStruct": {
                "date": "2024-04-11",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-07",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-09",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Alkermes, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this research study is to assess the safety and efficacy of ALKS 2680 compared to placebo, including whether participants taking ALKS 2680 experience a greater decrease in sleepiness and a decrease in cataplexy (\"sudden loss of muscle control\"), compared to participants taking placebo alone."
        },
        "conditionsModule": {
            "conditions": [
                "Narcolepsy Type 1"
            ],
            "keywords": [
                "Narcolepsy",
                "Cataplexy",
                "Orexin"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "4 mg ALKS 2680",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: ALKS 2680"
                    ]
                },
                {
                    "label": "6 mg ALKS 2680",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: ALKS 2680"
                    ]
                },
                {
                    "label": "8 mg ALKS 2680",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: ALKS 2680"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "ALKS 2680",
                    "description": "Oral tablet of ALKS 2680 for once daily administration",
                    "armGroupLabels": [
                        "4 mg ALKS 2680",
                        "6 mg ALKS 2680",
                        "8 mg ALKS 2680"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Oral tablet containing matching placebo for once daily administration",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in Mean Sleep Latency (MSL) on the Maintenance of Wakefulness Test (MWT) from baseline to Week 6",
                    "timeFrame": "Baseline to Week 6"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in Epworth Sleepiness Scale (ESS) from baseline to Week 6",
                    "description": "Epsworth Sleepiness Scale is a 4-point scale used to measure excessive sleepiness from 0 (would never doze) to 3 (high chance of \"dozing)",
                    "timeFrame": "Baseline to Week 6"
                },
                {
                    "measure": "Mean weekly cataplexy rate (WCR) as derived by subject cataplexy diary",
                    "timeFrame": "Measured at Week 5 and 6"
                },
                {
                    "measure": "Incidence of adverse events",
                    "timeFrame": "Up to 15 Weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* 18-70 years of age\n* Has a BMI \u226518 and \u226435 kg/m2\n* Meets the diagnostic criteria of Narcolepsy type 1 according to ICSD-3-TR guidelines. Additionally, meets the following criteria:\n\n  * Is HLA-DQB1\\*06:02-positive\n  * Has residual excessive daytime sleepiness and cataplexy\n* Is willing and able to discontinue any medications prescribed for the management of narcolepsy symptoms for at least 14 days and for the duration of study\n* Is willing to adhere to additional protocol requirements\n\nExclusion Criteria:\n\n* Significant comorbid medical conditions, including other sleep, cardiovascular, psychiatric, hepatic or other disorders may be exclusionary; eligibility will be determined on an individual basis by the study investigator",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Global Clinical Services",
                    "role": "CONTACT",
                    "phone": "US: 888-235-8008",
                    "email": "clinicaltrials@alkermes.com"
                },
                {
                    "name": "Global Clinical Services",
                    "role": "CONTACT",
                    "phone": "Global: 571-599-2701",
                    "email": "clinicaltrials@alkermes.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Study Medical Director, MD",
                    "affiliation": "Alkermes, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Alkermes Investigational Site",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30328",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Alkermes Investigational Site",
                    "status": "RECRUITING",
                    "city": "Macon",
                    "state": "Georgia",
                    "zip": "31210",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.84069,
                        "lon": -83.6324
                    }
                },
                {
                    "facility": "Alkermes Investigational Site",
                    "status": "RECRUITING",
                    "city": "Huntersville",
                    "state": "North Carolina",
                    "zip": "28708",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.41069,
                        "lon": -80.84285
                    }
                },
                {
                    "facility": "Alkermes Investigational Site",
                    "status": "RECRUITING",
                    "city": "Columbia",
                    "state": "South Carolina",
                    "zip": "78229",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.00071,
                        "lon": -81.03481
                    }
                },
                {
                    "facility": "Alkermes Investigational Site",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Vibrance-1 Study",
                    "url": "https://vibrancestudies.com/?utm_source=ClinicalTrials&utm_medium=Referral&utm_content=Listing&utm_campaign=Listing_Vibrance1"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009290",
                    "term": "Narcolepsy"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006970",
                    "term": "Disorders of Excessive Somnolence"
                },
                {
                    "id": "D000020919",
                    "term": "Sleep Disorders, Intrinsic"
                },
                {
                    "id": "D000020920",
                    "term": "Dyssomnias"
                },
                {
                    "id": "D000012893",
                    "term": "Sleep Wake Disorders"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12241",
                    "name": "Narcolepsy",
                    "asFound": "Narcolepsy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5637",
                    "name": "Cataplexy",
                    "relevance": "LOW"
                },
                {
                    "id": "M10021",
                    "name": "Disorders of Excessive Somnolence",
                    "relevance": "LOW"
                },
                {
                    "id": "M1717",
                    "name": "Sleepiness",
                    "relevance": "LOW"
                },
                {
                    "id": "M22242",
                    "name": "Parasomnias",
                    "relevance": "LOW"
                },
                {
                    "id": "M22654",
                    "name": "Sleep Disorders, Intrinsic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22655",
                    "name": "Dyssomnias",
                    "relevance": "LOW"
                },
                {
                    "id": "M15696",
                    "name": "Sleep Wake Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T4044",
                    "name": "Narcolepsy",
                    "asFound": "Narcolepsy",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}